undamentalytics Newsletter
Sign in

Bicycle Therapeutics PLC balance sheet

At the end of fiscal 2025, Bicycle Therapeutics PLC had total assets of $718m, total liabilities of $108m and shareholders' equity of $610m. It held $628m in cash against $0 of debt: net cash of $628m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents68000439339526880628470
Receivables—50512000—
Total current assets—77104156459369562929683538
Total assets—82110161480411595957718567
Accounts payable—2213613161010
Deferred revenue (current)—0110192025103—
Total current liabilities—9923365370675744
Long-term debt———15303031———
Total debt000153030313100
Total liabilities—29176613414022416410862
Shareholders' equity−47−709395346271371793610505
Non-controlling interests and other (assets − liabilities − equity)—122————————
Net debt (negative = net cash)−680015−409−309−496−849−628−470
Shares outstanding———21m30m30m42m69m69m70m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BCYC vs PLXAAPG vs BCYCBCYC vs VSTMADCT vs BCYC

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Bicycle Therapeutics PLC's SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bicycle Therapeutics PLC.